With a new center, All of Us tackles health data silos to power precision medicine; After Sarepta trial failure, families and doctors brace for another debate on Duchenne therapy

Taking stock of the drug industry, from the lab to the medicine chest

November 2, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe With a new center, All of Us tackles health data silos to power precision medicine NIH recently announced a $30 million grant to establish the Center for Linkage and Acquisition of Data, a new resource for the All of Us research program. By Katie Palmer STAT+ | After Sarepta trial failure, families and doctors brace for another debate on Duchenne therapy At issue is another Duchenne medicine's efficacy and another fight with regulators and payers over who gets access. By Jason Mast and Adam Feuerstein New antibiotic targets gonorrhea as well as last existing treatment, study shows The results of the Phase 3 clinical trial could lead to licensure of the first new treatment for gonorrhea in decades. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser